Paul Chaplin

Biography

Paul Chaplin MSc, Ph.D. has been the Chief Executive Officer and President at Bavarian Nordic A/S since May 28, 2014. Dr. Chaplin served as an Executive Vice President of Bavarian Nordic A/S from 2004 to May 28, 2014 and served as its Division President of Infectious Diseases until May 28, 2014. Dr. Chaplin served as the President of Infectious Diseases Division of Research & Development of Bavarian Nordic A/S. Dr. Chaplin served as the Chief Scientific Officer of Bavarian Nordic A/S. He served as Vice President, Research and Development of Bavarian Nordic A/S. He served as Managing Director of Bavarian Nordic GmbH. Dr. Chaplin served as General Manager of German Subsidiary of Bavarian Nordic Research Institute AS. Dr. Chaplin joined Bavarian Nordic A/S in 1999 as Manager of Immunology. Dr. Chaplin worked for several years at the Institute for Animal Health in the UK in the areas of cytokine and dendritic cell biology. Dr. Chaplin was involved in research and development of veterinary vaccines at CSIRO, the Cooperative Research Centre for Vaccine Technology in Australia for three years. Dr. Chaplin holds a PhD from Bristol University.

Research Interest

Pharmaceuticals